GLP-1 drugs could have a surprisingly large environmental payoff
摘要
研究显示,Ozempic和Wegovy等GLP-1减肥药物若广泛使用,可能通过抑制食欲减少热量摄入,进而改变全球食品需求。模拟结果表明,在肥胖成年人中普及此类药物,到2050年每年或可避免多达660万例死亡,并释放最多3200万公顷农业用地,面积略大于意大利。
GLP-1 weight-loss medicines such as Ozempic and Wegovy could affect much more than the waistlines of the people who take them. If widely used, our new research suggests these appetite-suppressing medicines could transform the global food system and free up vast areas of agricultural land.
The global food system is ultimately driven by demand. If people eat less, producers respond, affecting production, prices, trade, and how much land is needed. We used a powerful computer simulation to explore scenarios ranging from GLP-1 use concentrated in high-income countries to widespread global access.
With widespread use of these medicines among adults living with obesity, we estimate that reduced calorie intake could prevent up to 6.6 million deaths each year by 2050, while freeing up as much as 32 million hectares of agricultural land—an area slightly larger than Italy—for other uses.
转载信息
评论 (0)
暂无评论,来留下第一条评论吧